The RSNA Research and Education Foundation has awarded the 2010 Siemens Healthcare/RSNA grants to two researchers.
Hersh Chandarana, MD, of the New York University School of Medicine, has been awarded the Siemens Healthcare/RSNA Research Scholar Grant to study liver metastases, which are the main cause of death for patients with colon cancer. His study will use contrast-enhanced dual-energy CT to assess and predict response for patients undergoing chemotherapy. The grant award is $75,000 per year for a two-year study.
James Costello, MD, PhD, of Emory University, has been awarded the Siemens Healthcare/RSNA Research Fellow Grant to focus on the increased demand for lung transplants due to chronic lung disease. His project will look to reduce the need for invasive tests by developing an outpatient MRI examination for pre- and post-lung-transplant patients. The grant award is $50,000 for a one-year study.
The grants are made possible by the Malvern, PA-based company's support of the RSNA Research and Education Foundation.
Related Reading
Siemens sees rebound in Q3 results, July 29, 2010
Siemens wins first U.K. MRI scanner orders, July 22, 2010
Siemens launches OB ultrasound software, July 9, 2010
Siemens debuts new Acuson S2000 release, July 7, 2010
Siemens debuts SIERRA dose reduction effort, June 29, 2010
Copyright © 2010 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&fit=crop&h=100&q=70&w=100)
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
